Activated Coagulation Time and Hepcon Protamine Titration Device to Manage Unfractionated Heparin During Cardiopulmonary Bypass in a Hemophilia A Patient on Emicizumab.

Isaacs, James; Welsby, Ian J; Schroder, Jacob N; Onwuemene, Oluwatoyosi A

Isaacs, James; Welsby, Ian J; Schroder, Jacob N; Onwuemene, Oluwatoyosi A.

Afiliação

Isaacs J; Department of Medicine, Duke University Medical Center, Durham, NC.
Welsby IJ; Department of Anesthesiology, Duke University Medical Center, Durham, NC.
Schroder JN; Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, NC.
Onwuemene OA; Division of Hematology, Department of Medicine, Duke University Medical Center, Durham, NC. Electronic address: toyosi.onwuemene@duke.edu.

J Cardiothorac Vasc Anesth ; 35(11): 3299-3302, 2021 11.

Article em En | MEDLINE | ID: mdl-32928650

Assuntos

Hemofilia A; Heparina; Anticorpos Biespecíficos; Anticorpos Monoclonais Humanizados; Anticoagulantes; Ponte Cardiopulmonar; Hemofilia A/tratamento farmacológico; Heparina/efeitos adversos; Humanos; Preparações de Plantas; Protaminas; Tempo de Coagulação do Sangue Total

Palavras-chave

Hepcon protamine titration device; activated clotting time; cardiopulmonary bypass surgery; emicizumab; hemophilia A

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Heparina / Hemofilia A Limite: Humans Idioma: En Revista: J Cardiothorac Vasc Anesth Assunto da revista: ANESTESIOLOGIA / CARDIOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Nova Caledônia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google